| human | Q5 |
| P6178 | Dimensions author ID | 01177542444.68 |
| P227 | GND ID | 123547733 |
| P269 | IdRef ID | 069211531 |
| P213 | ISNI | 0000000116766084 |
| P244 | Library of Congress authority ID | n2001129833 |
| P3835 | Mendeley person ID | eduardo-franco1 |
| P8189 | National Library of Israel J9U ID | 987007376115905171 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 24396644X |
| P1207 | NUKAT ID | n2004099127 |
| P496 | ORCID iD | 0000-0002-4409-8084 |
| P8951 | Order of Canada recipient ID | 146-4629 |
| 146-4629 | ||
| P1053 | ResearcherID | C-6445-2014 |
| P1153 | Scopus author ID | 57190242638 |
| 57192109492 | ||
| 57192109812 | ||
| 57195541375 | ||
| 7103162396 | ||
| P10861 | Springer Nature person ID | 01177542444.68 |
| P214 | VIAF ID | 77224962 |
| P10832 | WorldCat Entities ID | E39PBJr7WBVPFHtdJhBmfmR9Xd |
| P108 | employer | McGill University | Q201492 |
| P734 | family name | Franco | Q17983447 |
| Franco | Q17983447 | ||
| Franco | Q17983447 | ||
| P735 | given name | Eduardo | Q18130894 |
| Eduardo | Q18130894 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q57089452 | Q57089452 |
| Q57089357 | A New Generation of Studies of Human Papillomavirus DNA Testing in Cervical Cancer Screening |
| Q111893052 | A Review of Ethical and Legal Aspects of Gender-Neutral Human Papillomavirus Vaccination |
| Q43524117 | A collaboration between cousins: The Canadian Journal of Public Health and the Canadian Society for Epidemiology and Biostatistics. |
| Q35199478 | A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine |
| Q51915982 | A new window into the natural history of human papillomavirus infection: a view from the ALTS (Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study) trial. |
| Q97516601 | A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers |
| Q57089486 | A prospective epidemiological study of gastrointestinal health effects due to the consumption of drinking water |
| Q33545461 | A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial) |
| Q57089509 | A randomized trial to evaluate the risk of gastrointestinal disease due to consumption of drinking water meeting current microbiological standards |
| Q57089501 | ARE THE APPARENT EFFECTS OF CIGARETTE SMOKING ON LUNG AND BLADDER CANCERS DUE TO UNCONTROLLED CONFOUNDING BY OCCUPATIONAL EXPOSURES? |
| Q36618315 | Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis |
| Q36389268 | Advances in prevention of cervical cancer and other human papillomavirus-related diseases |
| Q50065081 | Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol |
| Q57089517 | Age and lateness of referral as determinants of extra-ocular retinoblastoma |
| Q58565656 | Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study |
| Q57089342 | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer |
| Q24607403 | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer |
| Q26828840 | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. |
| Q57089332 | An elusive low-hanging fruit for public health: Gun violence prevention |
| Q57089423 | An overview of epidemiological and public health research on HPVs presented at the 21st International Papillomavirus Conference in Mexico City, 20-26 February 2004 |
| Q57089529 | Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach |
| Q36402443 | Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus |
| Q40299423 | Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening |
| Q40405504 | Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial |
| Q51565266 | Are endometrial polyps true cancer precursors? |
| Q36750373 | Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis |
| Q57089434 | Are we ready for a paradigm change in cervical cancer screening? |
| Q100749846 | Assessing 10-year safety of a single negative HPV test for cervical cancer screening: Evidence from FOCAL-DECADE cohort |
| Q33716315 | Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities. |
| Q58564989 | Assessing the Time Dependence of Prognostic Values of Cytology and Human Papillomavirus Testing in Cervical Cancer Screening |
| Q52033578 | Assessing the gain in diagnostic performance when combining two diagnostic tests. |
| Q44382596 | Assessment of control selection bias in a hospital-based case-control study of upper aero-digestive tract cancers. |
| Q40118285 | Assessment of mediators of racial disparities in cervical cancer survival in the United States |
| Q54471327 | Association between timing of surgery during menstrual cycle and prognosis in pre-menopausal breast cancer. |
| Q104285210 | Association of serum 25-hydroxyvitamin D with prevalence, incidence, and clearance of vaginal HPV infection in young women |
| Q57089492 | Associations between Cigarette Smoking and Each of 21 Types of Cancer: A Multi-Site Case-Control Study |
| Q36280196 | Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study |
| Q50534131 | Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking |
| Q40301885 | Assortative mixing as a source of bias in epidemiological studies of sexually transmitted infections: the case of smoking and human papillomavirus. |
| Q40203537 | Assortativity and Mixing by Sexual Behaviors and Sociodemographic Characteristics in Young Adult Heterosexual Dating Partnerships |
| Q43703804 | Awareness and knowledge about human papillomavirus among Inuit women in Nunavik, Quebec |
| Q57089391 | BROGLY ET AL. RESPOND |
| Q48482419 | Bernard Duval: the architect of Quebec's HPV immunization programme |
| Q35870615 | Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? |
| Q39948348 | Brief research report: uncertainty-inducing and reassuring facts about HPV: a descriptive study of French Canadian women. |
| Q43972807 | Burden of disease, health indicators and challenges for epidemiology in North America |
| Q57089493 | Cancer Causes Revisited: Human Papillomavirus and Cervical Neoplasia |
| Q33206390 | Cancer of the Uterine Cervix |
| Q91945356 | Cancers attributable to infections in Canada |
| Q57089525 | Catching up with history: Treatment of Wilms' tumor in a developing country |
| Q57089453 | Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection |
| Q40647908 | Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections |
| Q40257933 | Cervical Infection with Cutaneous Beta and Mucosal Alpha Papillomaviruses |
| Q56959445 | Cervical cancer control, priorities and new directions |
| Q37222484 | Cervical cancer screening following prophylactic human papillomavirus vaccination |
| Q36839786 | Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination |
| Q36679762 | Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none |
| Q33894231 | Cervical human papillomavirus detection is not affected by menstrual phase |
| Q57089455 | Cervical-cancer screening beyond the year 2000 |
| Q35154955 | Chapter 13: Primary screening of cervical cancer with human papillomavirus tests |
| Q36537615 | Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination |
| Q36584403 | Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer |
| Q36584407 | Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts |
| Q34562942 | Chapter 6: Epidemiology and transmission dynamics of genital HPV infection |
| Q96292520 | Characterization of the vaginal microbiome in women of reproductive age from five regions in Brazil |
| Q37006487 | Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection |
| Q44607469 | Combatting obesity - a helping hand from the business community |
| Q35951206 | Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted |
| Q46681608 | Commentary: Smoking and human papillomavirus infection: the pursuit of credibility for an epidemiologic association |
| Q38119752 | Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study |
| Q64136355 | Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial |
| Q39160423 | Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study |
| Q91354506 | Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico |
| Q39016242 | Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results |
| Q57089461 | Comparison of endocervical curettage and endocervical brushing |
| Q46555447 | Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo. |
| Q48510078 | Comparison of psychosocial outcomes in head and neck cancer patients receiving a coping strategies intervention and control subjects receiving no intervention |
| Q35870574 | Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial |
| Q33772648 | Comprehensive control of human papillomavirus infections and related diseases |
| Q51856187 | Comprehensive control of human papillomavirus infections and related diseases. |
| Q53078836 | Comprehensive control of human papillomavirus infections and related diseases. |
| Q52693479 | Computer-assisted multiple categorization of absorbance values in ELISA through pictorial emulation of 96-well plates. |
| Q36314457 | Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test |
| Q57089491 | Conventional Cervical Cytologic Smears vs. ThinPrep Smears |
| Q55673241 | Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. |
| Q35943659 | Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval |
| Q96220276 | Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens |
| Q57089519 | Correlation patterns of cancer relative frequencies with some socioeconomic and demographic indicators in Brazil: An ecologic study |
| Q92448690 | Corrigendum to "Cancers attributable to infections in Canada" [Prev. Med. 122 (2019) 109-117] |
| Q92448695 | Corrigendum to "Estimates of the future burden of cancer attributable to infections in Canada" [Prev. Med. 122 (2019) 118-127] |
| Q57089374 | Cost-effectiveness analysis: An essential tool to inform public health policy in cervical cancer prevention |
| Q44396284 | Cost-effectiveness of HPV 16, 18 vaccination in Brazil |
| Q57089339 | Counterpoint: Cervical Cancer Screening Guidelines--Approaching the Golden Age |
| Q38037763 | Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis |
| Q94504505 | Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: systematic review and meta-analysis |
| Q90464994 | Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction |
| Q96689004 | Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening |
| Q38642781 | Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study |
| Q57089375 | Delays in diagnosis and treatment among children and adolescents with cancer in Canada |
| Q37580631 | Detection and typing of human papillomavirus nucleic acids in biological fluids |
| Q45203440 | Detection of human herpes virus type 6 DNA in precancerous lesions of the uterine cervix |
| Q92978627 | Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women |
| Q36255806 | Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician |
| Q57089463 | Determinants of Low-Risk and High-Risk Cervical Human Papillomavirus Infections in Montreal University Students |
| Q34587057 | Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study |
| Q45365205 | Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada |
| Q42235271 | Determinants of human papillomavirus coinfections among Montreal university students: the influence of behavioral and biologic factors |
| Q44130173 | Determinants of human papillomavirus infection among Inuit women of northern Quebec, Canada |
| Q34315668 | Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis |
| Q36874450 | Diagnosis delays in childhood cancer: a review |
| Q57089534 | Diagnosis of Acute Acquired Toxoplasmosis with the Enzyme-Labelled Antigen Reversed Immunoassay for Immunoglobulin M Antibodies |
| Q50586894 | Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women. |
| Q36953602 | Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia |
| Q39669476 | Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study |
| Q57089418 | Different P105 Promoter Activities among Natural Variants of Human Papillomavirus Type 18 |
| Q96124329 | Directionality of genital human papillomavirus infection transmission within heterosexual couples: a systematic review and meta-analysis |
| Q40471804 | Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial. |
| Q93068571 | Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening |
| Q38984023 | Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women |
| Q57089348 | Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada |
| Q39754174 | Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion |
| Q40406236 | Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer? |
| Q57089344 | Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec |
| Q98384918 | Dual staining for p16/Ki-67 to detect high-grade cervical lesions: results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing (STAIN-IT) study |
| Q39553769 | Economic evaluation of strategies for managing women with equivocal cytological results in Brazil. |
| Q57896024 | Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months |
| Q43484583 | Effect of type of alcoholic beverage on the risks of upper aerodigestive tract cancers in Brazil |
| Q57089360 | Effectiveness of Cervical Cancer Screening at Different Ages |
| Q53821197 | Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): Interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial. |
| Q45552005 | Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial |
| Q36116814 | Electrofulguration for low-grade squamous intraepithelial lesions of the cervix (CIN 1). |
| Q57089337 | Embracing a new era in cervical cancer screening |
| Q34719623 | Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. |
| Q36231336 | Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination |
| Q57089470 | Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer |
| Q37078556 | Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination |
| Q57089435 | Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer |
| Q41970262 | Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil |
| Q52641439 | Epidemiologic programs for computers and calculators. Simple algorithms for the representation of deterministic and stochastic versions of the Reed-Frost epidemic model using a programmable calculator. |
| Q57089362 | Epidemiological methods: a view from the Americas |
| Q37941160 | Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies |
| Q25257290 | Epidemiology as a tool to reveal inequalities in breast cancer care |
| Q57089472 | Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer |
| Q90642299 | Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction |
| Q57089424 | Epidemiology of Cervical, Vulvar, and Vaginal Cancers |
| Q57089412 | Epidemiology of Oncogenic and Nononcogenic HPV Types, and the Evidence for Differences in Their Sexual Transmissibility |
| Q44915391 | Epidemiology's contributions to a Nobel Prize recognition |
| Q38041211 | Epidemiology, natural history and risk factors for anal intraepithelial neoplasia |
| Q57089353 | Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men |
| Q91945364 | Estimates of the future burden of cancer attributable to infections in Canada |
| Q47254918 | Estimating HPV DNA Deposition Between Sexual Partners Using HPV Concordance, Y Chromosome DNA Detection, and Self-reported Sexual Behaviors |
| Q57171640 | Estimating the current and future cancer burden in Canada: methodological framework of the Canadian population attributable risk of cancer (ComPARe) study |
| Q36610489 | Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK |
| Q78552974 | Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women |
| Q44744861 | Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR. |
| Q34964786 | Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens |
| Q91001532 | Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction |
| Q50758741 | Evidence-based policy recommendations on cancer screening and prevention. |
| Q57089495 | Factors Influencing Regional Lymph Node Metastasis from Laryngeal Carcinoma |
| Q34705021 | Factors associated with cervical cancer screening uptake among Inuit women in Nunavik, Quebec, Canada |
| Q51003447 | Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. |
| Q35530646 | Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR. |
| Q92781104 | Genetic variants in CYP and GST genes, smoking and risk for head and neck cancers: a gene-environment interaction hospital-based case-control study among Canadian Caucasians |
| Q35463790 | Genital transmission of human papillomavirus in recently formed heterosexual couples |
| Q92947755 | Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia |
| Q44606574 | Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia |
| Q33744003 | Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences |
| Q37461977 | Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older |
| Q44317446 | HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. |
| Q57089446 | HIV-Positive Notification and Behavior Changes in Montreal Injection Drug Users |
| Q61480154 | HLA and KIR Associations of Cervical Neoplasia |
| Q51751615 | HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. |
| Q40673772 | HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status |
| Q39338815 | HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer |
| Q42246425 | HPV testing with cytology triage for cervical cancer screening in routine practice |
| Q91466951 | Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study |
| Q57089393 | Haptoglobin phenotype and risk of cervical neoplasia: A case-control study |
| Q37870300 | Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix |
| Q54561703 | High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. |
| Q57089413 | High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia |
| Q45078677 | How multidisciplinary research advanced the mission of cervical cancer prevention |
| Q64229362 | Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals |
| Q57089326 | Human Papillomavirus Vaccination: Making Sense of the Public Controversy |
| Q91167741 | Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women |
| Q57089350 | Human Papillomavirus Vaccines |
| Q91822163 | Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples |
| Q51513988 | Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. |
| Q57089345 | Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix |
| Q34487394 | Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix |
| Q35867881 | Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix |
| Q33744518 | Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women |
| Q53028990 | Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. |
| Q35210588 | Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments |
| Q26995703 | Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy |
| Q47583544 | Human papillomavirus and cervical cancer: burden of illness and basis for prevention. |
| Q81451713 | Human papillomavirus and cervical dysplasia in Nunavut: prelude to a screening strategy |
| Q40180184 | Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study |
| Q53556529 | Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. |
| Q33797578 | Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity |
| Q47650204 | Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia |
| Q57089489 | Human papillomavirus infection in postmenopausal women with and without hormone therapy |
| Q39907394 | Human papillomavirus infections among couples in new sexual relationships |
| Q53612097 | Human papillomavirus infections with multiple types and risk of cervical neoplasia. |
| Q57089414 | Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia |
| Q39477130 | Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial |
| Q30878077 | Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis |
| Q33887322 | Human papillomavirus type 16 viral load measurement as a predictor of infection clearance |
| Q54582551 | Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. |
| Q46201572 | Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix |
| Q42256759 | Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions |
| Q57089376 | Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention |
| Q88531230 | Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review |
| Q57089349 | Human papillomavirus vaccines |
| Q38255277 | Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs |
| Q36417526 | Human papillomavirus variants among Inuit women in northern Quebec, Canada |
| Q92143433 | Improving the reporting of cancer-specific mortality and survival in research using cancer registry data |
| Q37236452 | Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial |
| Q45781715 | Incidence of Norwalk virus infections during a prospective epidemiological study of drinking water-related gastrointestinal illness |
| Q41080793 | Incidence, persistence, and determinants of human papillomavirus infection in a population of Inuit women in northern Quebec |
| Q90863506 | Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study |
| Q57089351 | Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity |
| Q48047616 | Independent Scientists Provide Guidance for the Future of Cervical Cancer Screening |
| Q38045335 | Infectious agents |
| Q51813724 | Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. |
| Q42272592 | Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study |
| Q35577988 | Innovations in understanding the biology of cervical cancer |
| Q57089395 | Insulin-like Growth Factor-I and Risk of High-Grade Cervical Intraepithelial Neoplasia |
| Q37580641 | Integrating human papillomavirus vaccination in cervical cancer control programmes |
| Q39807848 | Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control |
| Q37306153 | Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean |
| Q50147502 | Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization |
| Q57089474 | Interaction between Tobacco and Alcohol Consumption and the Risk of Cancers of the Upper Aero-Digestive Tract in Brazil |
| Q33362569 | Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer |
| Q40299388 | Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm |
| Q36159860 | Inuit women's attitudes and experiences towards cervical cancer and prevention strategies in Nunavik, Quebec |
| Q97435189 | Invited Commentary: Rethinking Cervical Cancer Elimination in Terms of Lifetime Risk Rather Than Arbitrarily-Defined Age-Standardized Incidence Rates |
| Q33883585 | Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions |
| Q57089416 | Is HPV testing with cytological triage a more logical approach in cervical cancer screening? |
| Q36628105 | Is colposcopy warranted in women with external anogenital warts? |
| Q57089365 | Is the UK ready to embrace HPV testing? |
| Q43076459 | Is there a need for a new journal devoted to preventive medicine? |
| Q57089324 | Journal editors as curators of scholarship: A case study in repairing the scientific record |
| Q36765937 | Koilocytosis in oral squamous cell carcinoma: what does it mean? |
| Q92339508 | Lack of Association between Human Papillomavirus Types 6 and 11 Genetic Variants and Cervical Abnormalities: The Ludwig-McGill Cohort Study |
| Q54578561 | Lack of agreement between cervicography and cytology and the effect of human papillomavirus infection and viral load. |
| Q90478104 | Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals |
| Q57089504 | Lateness of diagnosis of oral and oropharyngeal carcinoma: Factors related to the tumour, the patient and health professionals |
| Q91321439 | Limitations of simulation models for cervical cancer screening - Authors' reply |
| Q48907683 | Loss of quality of life associated with genital warts: baseline analyses from a prospective study |
| Q47931057 | Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions |
| Q90604069 | Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV): design and methods for a randomised controlled trial |
| Q38155065 | Lung cancer screening: review and performance comparison under different risk scenarios |
| Q53836692 | L’inconvénient du changement de paradigme dans l’édition savante en sciences biomédicales : l’arrivée des éditeurs prédateurs. |
| Q26827609 | Making Prospective Registration of Observational Research a Reality |
| Q57089426 | Male Circumcision and AIDS in Africa |
| Q33998888 | Management of low-grade cervical lesions in young women |
| Q57089368 | Managing low grade and borderline cervical abnormalities |
| Q46241625 | Managing low-grade cervical lesions |
| Q55065345 | Maté, coffee, and tea consumption and risk of cancers of the upper aerodigestive tract in southern Brazil. |
| Q42190856 | Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. |
| Q47863746 | Mobile Screening Units for the Early Detection of Cancer: A Systematic Review |
| Q93213979 | Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing |
| Q31030012 | Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada |
| Q54746250 | Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. |
| Q51466515 | Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. |
| Q57089506 | Molecular Variant Analysis as an Epidemiological Tool to Study Persistence of Cervical Human Papillomavirus Infection |
| Q57089464 | Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia |
| Q57089532 | Monoclonal Antibody Characterization of Plasmodium Falciparum Antigens |
| Q57089398 | Multiparameter Calibration of a Natural History Model of Cervical Cancer |
| Q57089379 | Newly-isolated HPV97, related to HPV18 and 45 is frequently detected in HIV-positive men from the montreal area |
| Q34050063 | No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women |
| Q40596292 | No role for human papillomavirus infection in oral cancers in a region in southern India |
| Q49711128 | Non-Vaccine-Type HPV Prevalence after Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection |
| Q28195592 | Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population |
| Q40619132 | Nonlinear association between betel quid chewing and oral cancer: Implications for prevention |
| Q57089438 | Occurrence of Cervical Infection with Multiple Human Papillomavirus Types is Associated with Age and Cytologic Abnormalities |
| Q57089456 | Oncogenic Human Papillomavirus Infection and Cervical Lesions in Aboriginal Women of Nunavut, Canada |
| Q40026216 | Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis |
| Q38660469 | Optimizing secondary prevention of cervical cancer: Recent advances and future challenges |
| Q36319941 | Optimizing technology for cervical cancer screening in high-resource settings |
| Q33206391 | Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers |
| Q56580675 | Ottawa Statement from the Sparking Solutions Summit on Population Health Intervention Research |
| Q47215939 | Outcomes and cost comparisons after introducing a robotics program for endometrial cancer surgery |
| Q57089381 | Ovarian cancer and oral contraceptives |
| Q57089498 | Parental Exposures to Pesticides and Risk of Wilms' Tumor in Brazil |
| Q35006142 | Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV2001. |
| Q37001336 | Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis |
| Q28727717 | Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction |
| Q40740118 | Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study |
| Q57089369 | Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women |
| Q92080357 | Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada |
| Q57089354 | Persistent HPV Infection and Cervical Cancer Risk: Is the Scientific Rationale for Changing the Screening Paradigm Enough? |
| Q34571747 | Persistent human papillomavirus infection and cervical neoplasia |
| Q57089523 | Plasminogen activator expression and steroid hormone receptors in female breast cancer: A multifactorial study |
| Q35868060 | Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association |
| Q37111066 | Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection |
| Q57089400 | Polymorphism of the L1 Capsid Gene and Persistence of Human Papillomavirus Type 52 Infection in Women at High Risk or Infected by HIV |
| Q57089356 | Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35 |
| Q45332032 | Polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia |
| Q57089451 | Polymorphisms of the Human Leukocyte Antigen DRB1 and DQB1 Genes and the Natural History of Human Papillomavirus Infection |
| Q47333961 | Population health intervention research: A renewed commitment to promoting a science of solutions |
| Q57089346 | Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis |
| Q37224673 | Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico |
| Q45229241 | Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine |
| Q90250026 | Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions |
| Q77747965 | Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck |
| Q47424220 | Predictors of cervical coinfection with multiple human papillomavirus types |
| Q57089334 | Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study |
| Q57089480 | Predictors of professional diagnostic delays for upper aerodigestive tract carcinoma |
| Q57089481 | Preoperative irradiation therapy and radical hysterectomy: prognostic value of tumor regression after initial irradiation of squamous cell carcinoma of the cervix |
| Q57089511 | Presentation Risk factors for second cancers of the upper respiratory and digestive systems: A case-control study |
| Q57089383 | Prevalence and Age Distribution of Human Papillomavirus Infection in a Population of Inuit Women in Nunavik, Quebec |
| Q46682247 | Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community. |
| Q30890822 | Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial |
| Q57089371 | Prevalence, Clearance, and Incidence of Anal Human Papillomavirus Infection in HIV‐Infected Men: The HIPVIRG Cohort Study |
| Q96640968 | Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report |
| Q91279137 | Prevention of cervical cancer in Latin America: Future challenges and opportunities |
| Q46841410 | Preventive medicine: new editorial office but the same vision |
| Q36451743 | Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study |
| Q36891219 | Process of care failures in invasive cervical cancer: systematic review and meta-analysis |
| Q57089513 | Prognostic factors in laryngeal cancer patients submitted to surgical treatment |
| Q57089427 | Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma |
| Q44820462 | Prognostic value of measuring load of human papillomavirus DNA in cervical samples: an elusive target |
| Q57089428 | Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine |
| Q40744526 | Projected Impact of HPV and LBC Primary Testing on Rates of Referral for Colposcopy in a Canadian Cervical Cancer Screening Program |
| Q37780818 | Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. |
| Q36899064 | Prophylactic human papillomavirus vaccines: potential for sea change |
| Q35640036 | Prospects for controlling cervical cancer at the turn of the century |
| Q57089507 | Race and gender influences on the survival of patients with mouth cancer |
| Q33691607 | Radiodiagnostic imaging in pregnancy and the risk of childhood malignancy: raising the bar. |
| Q43500319 | Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). |
| Q57089431 | Randomized controlled trials of HPV testing and pap cytology: Toward evidence-based cervical cancer prevention |
| Q57089432 | Rapport du Forum Pancanadien sur la Prévention et la Maîtrise du Cancer du col Utérin de 2003 |
| Q57089403 | Re: Human Papillomavirus Type 16 and 18 Variants: Race-Related Distribution and Persistence |
| Q57089385 | Reassessing the Epidemiology of Human Papillomavirus Infection: Back to Basics |
| Q40577405 | Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial |
| Q37306157 | Recommendations for cervical cancer prevention in Latin America and the Caribbean |
| Q50857682 | Relationship between dental factors and risk of upper aerodigestive tract cancer. |
| Q35961124 | Report of the 2003 pan-Canadian forum on cervical cancer prevention and control. |
| Q35950243 | Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study |
| Q57089404 | Reproductive health of adolescent girls perinatally infected with HIV |
| Q57089340 | Response |
| Q57089405 | Response to Pretorius and Belinson |
| Q57697560 | Restoring Dignity in Academic Publishing Is a Collective Duty |
| Q57089465 | Risk behaviour change and HIV infection among injection drug users in Montreal |
| Q39280687 | Risk factors for oral cancer in Brazil: a case-control study. |
| Q36135097 | Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy |
| Q35920456 | Role and limitations of epidemiology in establishing a causal association |
| Q34637840 | Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec |
| Q57089387 | Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia |
| Q55361673 | Self-sampling for cervical cancer screening: Empowering women to lead a paradigm change in cancer control. |
| Q41665364 | Sexual transmission of oral human papillomavirus infection among men. |
| Q57089329 | Should we lower the age for routine HPV vaccination in the United States? |
| Q51665170 | Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. |
| Q57089336 | Sobering realizations in cancer prevention and screening and their lessons |
| Q48069984 | Striving for excellence while adapting to change: redefining our mission of serving the preventive medicine community |
| Q40509494 | Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community |
| Q89843703 | Surgeon and hospital volume outcomes in bariatric surgery: a population-level study |
| Q28236008 | Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial |
| Q40469500 | Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women. |
| Q57089327 | The Downside of the Shifting Paradigm of Scholarly Publishing in the Biomedical Sciences: Predatory Publishing |
| Q111598972 | The IARC Perspective on Cervical Cancer Screening |
| Q57089422 | The Role of Human Papillomaviruses in Cancer |
| Q57089516 | The Sexually Transmitted Disease Model for Cervical Cancer |
| Q42272939 | The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec |
| Q91945414 | The burden of cancer attributable to modifiable risk factors in Canada: Methods overview |
| Q57089499 | The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome: North American experience |
| Q35613579 | The epidemiology of cervical cancer |
| Q36365671 | The epidemiology of genital human papillomavirus infection |
| Q37620556 | The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change |
| Q37124824 | The frequency of HLA alleles in a population of Inuit women of northern Quebec |
| Q92114237 | The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042 |
| Q40884750 | The future of HPV testing in clinical laboratories and applied virology research |
| Q48588004 | The impact of anogenital warts on health-related quality of life: a 6-month prospective study |
| Q43588378 | The impact of intolerance of uncertainty on anxiety after receiving an informational intervention about HPV: a randomised controlled study |
| Q57089476 | The influence of parental age on the risk of Wilms’ tumour |
| Q36171005 | The laboratory diagnosis of genital human papillomavirus infections |
| Q93500731 | The merits of new alternatives to the Papanicolaou test |
| Q43919306 | The natural history of type-specific human papillomavirus infections in female university students. |
| Q57089420 | The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia |
| Q47293447 | The performance of mobile screening units in a breast cancer screening program in Brazil. |
| Q48643518 | The psychosocial impact of an abnormal cervical smear result |
| Q37719631 | The road ahead for cervical cancer prevention and control |
| Q93056760 | The role of healthcare providers in HPV vaccination programs - A meeting report |
| Q57089484 | The role of professional diagnostic delays in the prognosis of upper aerodigestive tract carcinoma |
| Q35571815 | Toward a reduction of the global burden of cervical cancer |
| Q57089347 | Towards more eclectic evidence-based medicine in cancer prevention and control |
| Q44474511 | Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale |
| Q57089500 | Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types |
| Q98394097 | Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples |
| Q40564382 | Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study |
| Q57089330 | Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study |
| Q44576798 | Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination |
| Q35072460 | Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer |
| Q91279179 | Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study |
| Q33950256 | Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples |
| Q33358972 | Use of latent class models to accommodate inter-laboratory variation in assessing genetic polymorphisms associated with disease risk |
| Q28476849 | Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study |
| Q43187352 | Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis |
| Q33704870 | Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection |
| Q39487464 | Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. |
| Q34806423 | Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness? |
| Q57089408 | Vaccination against human papillomavirus |
| Q36065397 | Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control |
| Q57089341 | Vaccination and Screening in Cervical Cancer Control and Prevention |
| Q93130684 | Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study |
| Q52573825 | Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. |
| Q33588095 | Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies |
| Q57089443 | Viral load as a predictor of the risk of cervical intraepithelial neoplasia |
| Q57089409 | Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix |
| Q90661137 | Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age |
| Q46347909 | Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. |
| Q37736877 | What is the role of HPV typing in the United States now and in the next five years in a vaccinated population? |
| Q43231234 | What makes an eLife paper in epidemiology and global health? |
| Q46775905 | Who's Not Protected in the Herd? Factors Associated with Vaccine-Type HPV in Unvaccinated Women |
| Q35889806 | Women's intentions to receive cervical cancer screening with primary human papillomavirus testing |
| Q34374999 | Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program |
| Q40915197 | World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer |
| Q40056191 | Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study |
| Q42251001 | cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens |
| Q35639506 | p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review |
| Q3487716 | Canadian Society for Epidemiology and Biostatistics | chairperson | P488 |
Search more.